David Gold

Senior Associate

New York

David Gold is a Senior Associate in the New York office and a member of Orrick’s Corporate Business Unit and M&A and Private Equity Group.

David advises private and public companies on domestic and cross-border transactions in the technology, life sciences, and energy and infrastructure sectors. He regularly advises clients on complex M&A transactions, joint ventures, and general corporate matters. 

David is passionate about his role as a trusted advisor to clients, and he immerses himself in the businesses of his clients to enable him to deliver impactful and strategic legal services.

Before joining Orrick, David practiced at another international law firm in New York.

 

  • Technology

    Shopify Inc. in several transactions, including its acquisitions of 6 River Systems ($450 million), Donde Fashion ($51 million), Tictail ($17 million), Handshake Corp. (terms not disclosed), and an acquihire (terms not disclosed)

    Pitney Bowes Inc. in its sale of the Tacit Knowledge digital commerce solutions business to Grid Dynamics

    Sailthru Inc., a New York based marketing automation firm, in its equity sale to Campaign Monitor

    Avaya Inc. in connection with its acquisition of the outstanding equity of CTIntegrations, LLC

    Energy and Infrastructure

    Affiliates of Macquarie Group Limited in several transactions, including the following:

    • The acquisition of the outstanding equity of Cyrq Energy, Inc., a U.S. geothermal power company based in Utah
    • The acquisition of the outstanding equity of Hudson Ranch I Holdings LLC, a geothermal power company based in California
    • The joint sale by Macquarie and Skanska of the outstanding equity of Elizabeth River Crossings HoldCo LLC, which operates and maintains the Elizabeth River Tunnels Project, to Abertis and Manulife Investment Management
    • The sale of the outstanding equity of Fraser Surrey Docks, a Canadian marine terminal, to DP World
    • The sale of the outstanding equity of Halterm, a Canadian marine terminal, and Penn Terminals, a Pennsylvania marine terminal, to PSA International

    Enlight Renewable Energy Ltd in its acquisition of a controlling interest in Clenera, LLC and several renewable energy projects in the U.S.

    Life Sciences

    ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) in several transactions, including the following:

    • The acquisition of three generic products and one branded product from Sandoz Inc.
    • The acquisition of a U.S. portfolio of 23 generic products from Amerigen Pharmaceuticals, Ltd.
    • The acquisition of the generic product Fluconazole from Harris Pharmaceutical, Inc.
    • The acquisition of the outstanding equity of WellSpring Pharma Services, Inc. a Canadian contract development and manufacturing organization

    Guide Therapeutics, Inc., a biotechnology company developing precision genetic medicines, in its equity sale to Beam Therapeutics Inc.

    Euclid Systems Corporation, a global leader in myopia treatment, in its equity sale to an affiliate of Hillhouse Capital Group

    Sizewise, a global medical equipment manufacturer, in its sale to Agiliti (NYSE: AGTI), a service provider to the U.S. healthcare industry ($230 million)

    While at his prior firm, represented Merck & Co. in its acquisitions of Cubist Pharmaceuticals and Idenix Pharmaceuticals

    Transportation

    Fisker Inc. (NYSE: FSR), an electric vehicle manufacturer, in its sale to Spartan Energy Acquisition Corp., a SPAC sponsored by an affiliate of Apollo Global Management, Inc.

    Battle Motors Inc. in its acquisition of the outstanding equity of Crane Carrier Company, LLC, a commercial vehicle OEM

    SPII Holdings Inc., a company controlled by DryShips Inc.’s chairman and CEO George Economou, in a “go-private” transaction